Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Reduction of Breast Enlargement Using the Da Vinci Xi Robot

NCT04597515 · GCS Ramsay Santé pour l'Enseignement et la Recherche · Updated 22 Oct 2020

What is being tested
Robot Breast reduction surgery
For
Breast Hypertrophy
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 5 people. The full rules are on the registry page.
Where
France
When
Starts or started 1 Nov 2020, ends 30 Nov 2022. Registered 22 Oct 2020.
Results
None posted yet.

In the researchers' words

Breast enlargement reductions are frequent interventions. One of the main issue associated with this surgery remains the ransom scar, wide at the periareolar level, vertical at the subareolar level and in the submammary groove. The expected result is to achieve a reduction in breast enlargement with no visible scar using Da Da Vinci Xi robot.
ClinicalTrials.gov, NCT04597515

Sites

  • Hôpital Privé d'AntonyAntony, IDF, France